Bentong Yu

2.3k total citations · 1 hit paper
56 papers, 1.3k citations indexed

About

Bentong Yu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Bentong Yu has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Bentong Yu's work include Esophageal Cancer Research and Treatment (10 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Cancer-related molecular mechanisms research (9 papers). Bentong Yu is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Cancer-related molecular mechanisms research (9 papers). Bentong Yu collaborates with scholars based in China, South Korea and United States. Bentong Yu's co-authors include Hezhong Chen, Mingxi Gan, Tianyu Han, Jianbin Wang, Zhigang Li, Baoquan Song, Yifeng Sun, Lijie Tan, Yang Yang and Xufeng Guo and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

Bentong Yu

55 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

2022 161 citations Jun Liu, Yang Yang et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bentong Yu China	22	577	496	403	314	240	56	1.3k
Yuko Kitagawa Japan	23	539 0.9×	582 1.2×	405 1.0×	466 1.5×	331 1.4×	108	1.6k
Hong Zhu China	18	324 0.6×	243 0.5×	371 0.9×	437 1.4×	169 0.7×	62	1.3k
Jun Hihara Japan	24	787 1.4×	803 1.6×	322 0.8×	466 1.5×	190 0.8×	128	1.7k
Jianxin Cui China	22	537 0.9×	342 0.7×	580 1.4×	361 1.1×	453 1.9×	92	1.5k
Hye Won Lee South Korea	19	318 0.6×	171 0.3×	484 1.2×	310 1.0×	259 1.1×	53	1.2k
Christina Hackl Germany	21	152 0.3×	345 0.7×	492 1.2×	442 1.4×	216 0.9×	48	1.3k
Sun Ah Kim South Korea	15	201 0.3×	260 0.5×	260 0.6×	227 0.7×	168 0.7×	25	1.1k
Ivana Cataldo Italy	21	235 0.4×	308 0.6×	302 0.7×	475 1.5×	200 0.8×	49	1.2k
Hideaki Kinugasa Japan	20	280 0.5×	255 0.5×	447 1.1×	531 1.7×	470 2.0×	64	1.2k

Countries citing papers authored by Bentong Yu

Since Specialization

Citations

This map shows the geographic impact of Bentong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bentong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bentong Yu more than expected).

Fields of papers citing papers by Bentong Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bentong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bentong Yu. The network helps show where Bentong Yu may publish in the future.

Co-authorship network of co-authors of Bentong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Bentong Yu. A scholar is included among the top collaborators of Bentong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bentong Yu. Bentong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Bentong, Tao Huang, Zhenhua Zhou, et al.. (2025). Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay. ESMO Open. 10(7). 105323–105323. 1 indexed citations

Wu, Yuhao, et al.. (2024). Superoxide dismutase mimetic nanozymes attenuate cardiac microvascular ischemia–reperfusion injury associated with hyperhomocysteinemia. Chemical Engineering Journal. 486. 150177–150177. 12 indexed citations

Xi, Yong, et al.. (2024). Comprehensive analysis of lung adenocarcinoma: Unveiling differential gene expression, survival‐linked genes, subtype stratification, and immune landscape implications. Environmental Toxicology. 40(7). 961–974.

Wang, C., et al.. (2023). 492P Penpulimab-based combination neoadjuvant/adjuvant therapy for patients with resectable locally advanced non-small cell lung cancer: Preliminary results from a phase II study (ALTER-L043). Annals of Oncology. 34. S1655–S1655. 2 indexed citations

Xi, Yong, et al.. (2023). Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy. Immunological Reviews. 321(1). 94–114. 62 indexed citations

Yu, Bentong, Mingshan Liu, Chuan Xu, et al.. (2023). Aggregation‐Induced Emission Photosensitizer‐Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy. Advanced Healthcare Materials. 13(11). e2303643–e2303643. 17 indexed citations

Yang, Jie, et al.. (2023). Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database. Frontiers in Surgery. 10. 1108732–1108732. 1 indexed citations

Mao, Na, et al.. (2023). Impact of endoscopic thoracic R4 sympathicotomy combined with R3 ramicotomy for primary palmar hyperhidrosis. Frontiers in Surgery. 10. 1144299–1144299. 3 indexed citations

Yang, Yang, Jun Liu, Zhichao Liu, et al.. (2023). Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study. Journal of Thoracic and Cardiovascular Surgery. 167(3). 838–847.e1. 25 indexed citations

10.

Jiang, Xun, Chunlin Ye, Yong Xi, et al.. (2023). Single-center experience of transitioning from video-assisted laparoscopic to robotic Heller myotomy with Dor fundoplication for esophageal motility disorders. BMC Surgery. 23(1). 341–341. 2 indexed citations

11.

Zhong, Yifan, Chuang Cai, Tao Chen, et al.. (2023). PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer. Nature Communications. 14(1). 7513–7513. 27 indexed citations

12.

Liu, Jun, Yang Yang, Zhichao Liu, et al.. (2022). Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 10(3). e004291–e004291. 161 indexed citations breakdown →

13.

Yang, Yang, Li Zhu, Yan Cheng, et al.. (2022). Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study). BMC Cancer. 22(1). 506–506. 24 indexed citations

14.

Lü, Zhuo, Tianyu Han, Tao Wang, et al.. (2022). OXCT1 regulates NF-κB signaling pathway through β-hydroxybutyrate-mediated ketone body homeostasis in lung cancer. Genes & Diseases. 10(2). 352–355. 7 indexed citations

15.

Wang, C., et al.. (2021). 1169TiP Penpulimab-based combination neoadjuvant/adjuvant therapy for patients with resectable locally advanced non-small cell lung cancer: A phase II clinical study (ALTER-L043). Annals of Oncology. 32. S938–S938. 1 indexed citations

16.

Zheng, Yuyan, Chengqiang Li, Bentong Yu, et al.. (2021). Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design. JTCVS Open. 9. 293–299. 16 indexed citations

17.

Xu, Qirong, et al.. (2021). Long non-coding RNA MEG3 mediates the miR-149-3p/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer. Journal of Translational Medicine. 19(1). 264–264. 30 indexed citations

18.

Lü, Zhuo, Xiaomei Wang, Yufeng Liu, et al.. (2020). E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer. Cellular Signalling. 69. 109543–109543. 39 indexed citations

19.

Chen, Shibiao, Sheng Liu, Xiang Ling, et al.. (2019). Inhibition of mitochondrial autophagy protects donor lungs for lung transplantation against ischaemia‐reperfusion injury in rats via the mTOR pathway. Journal of Cellular and Molecular Medicine. 23(5). 3190–3201. 15 indexed citations

20.

Pan, Xiang, Rong Zhang, Mingxi Gan, et al.. (2017). GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer.. PubMed Central. 9(9). 4217–4226. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact